Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

More stories in CTech

Drugs

98 stories about Drugs

1,000% stock increase: The story behind Eli Lilly’s pharmaceutical dominance
14.08.24|Viki AuslenderBeating second-quarter forecasts mainly due to its weight loss and diabetes drugs, Eli Lilly, the company aspiring to be worth a trillion dollars, has invested heavily in innovative developments, becoming the pharmaceutical manufacturer with the highest market value in the world.
Why are Teva shares surging and how does it plan to keep it up
04.04.24|Uri Tel TenneSince the beginning of the year, Teva's shares have risen by about 36%, and are among the best performing stocks on the Tel Aviv Stock Exchange. Why is this happening and how is the company's CEO planning to build on the momentum?
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO
19.02.20|Sophie ShulmanTeva’s stock fluctuation is not the result of wrongdoing regarding the U.S. opioid abuse epidemic, but rather something born of the creativity of lawyers, Kåre Schultz said Wednesday at the company’s annual press conference in Tel Aviv
Over-the-Counter Drug Prices in Israel are Much Higher Than Overseas
17.02.20|Orna YefetThe Israeli Ministries of Health and Economy summoned OTC drug manufacturers and distributors for meetings after a study found prices are 37% higher on average in Israel
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
16.02.20|Lilach BaumerOn Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%
Teva’s Small Print Gives Rise to Optimism
13.02.20|Sophie ShulmanThe improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
Teva Fights Muddy Reputation With Positive Report
23.01.20|Sophie ShulmanCalcalist obtained a report commissioned by the Israeli drugmaker that details its economic contribution to the countries in which it operates
Fat Melting Startup Raziel Therapeutics Raises $22 Million
19.12.19|Adi PickThe company's drug is injected into subcutaneous fat where it causes immediate fat cell death at the injection site, resulting in a reduction of fat tissue
Teva in Talks With U.S. DoJ to End Price-Fixing Probe, Report Says
26.11.19|CTechThe Israeli drugmaker, along with several other companies investigated in the matter, have been holding talks on the subject for the past six months, Bloomberg reported
Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
17.11.19|Navit ZomerThe Israeli drugmaker’s manufacturing facility in Kfar Saba, already experienced with manufacturing cash cow Copaxone, will oversee the process of filling the syringes with the biological drug and also conduct quality control tests
RedHill Receives FDA Approval for H. Pylori Gastric Drug
05.11.19|Tzally GreenbergH. pylori is a type of drug-resistant gastric bacteria linked with increased risks of developing ulcers and stomach cancer
Teva Overcomes One Hurdle, Many Still Ahead
23.10.19|Hezi SternlichtThe Israeli drugmaker announced on Monday two major achievements regarding the opioid abuse lawsuits against it; but even without taking into consideration its additional legal complications, the settlements it has reached will severely strain its resources
Teva Part of $50 Billion Opioid Settlement Deal, Report Says
17.10.19|Hezi SternlichtTeva, a second drugmaker, and the three largest drug distributors in the U.S. have agreed with multiple states on a settlement framework ahead of Monday’s trial, the New York Times reported Thursday
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says
16.10.19|Hezi SternlichtThe Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
Allergan Says Teva Bears Sole Liability for Actavis' Actions
02.09.19|Hezi SternlichtActavis, which Teva bought from Allergan in 2016 for $40.5 billion, was one of the top U.S. sellers of opioids in 2006-2012
Teva Faces New Opioid-Related Lawsuit in West Virginia
25.08.19|Hezi SternlichtThe lawsuit seems to be unrelated to the trial set to start against Teva and other opioid manufacturers in October in Ohio federal court
Telegrass' Marijuana Operation: Method, Testimonies, and Question Marks
10.07.19|Amir KurzOn March 12, Israel Police arrested 42 people suspected of holding top management positions in Israeli drug distribution network Telegrass, which operated via encrypted instant messaging app Telegram
Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit
27.05.19|Hezi SternlichtTeva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation's opioid addiction crisis
This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices
15.05.19|Hezi Sternlicht, Ran Abramson, and Tomer GanonA 524-page civil lawsuit filed Friday in the U.S. alleges that 20 generic drugmakers colluded to influence drug prices, with executives meeting regularly to set prices and split the market
Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI
02.05.19|Hezi SternlichtTeva is selling the plant following its 2017 plan to ameliorate its crippling debt by divesting non-core businesses and closing or selling many of its manufacturing plants

About CTech Terms of Use Privacy Policy

Back to Top